DOSSIER · 13F-HR · Q1 2026
GILEAD SCIENCES, INC.
$2.1B in tracked AUM across 6 positions as of Q1 2026.
GS
CIK 0000882095 · last filed Mar 31, 2026
AI Analysis · Q1 2026
Portfolio Overview
The filing for Gilead Sciences, Inc. (CIK: 0000882095) reveals a highly specialized investment portfolio totaling $1.65 billion as of September 30, 2025. This represents a significant appreciation in portfolio value, increasing by 29.0% from the $1.28 billion reported in the previous quarter. The portfolio is exceptionally concentrated, comprising only seven holdings. This lack of broad diversification indicates that the capital deployment is not intended for general mark...
Quarter at a glance — Q1 2026
Position-change comparison pending.
No quarter-over-quarter changes available.
Top 10 holdings
By portfolio weight as of Q1 2026.